Live Breaking News & Updates on Calcimedica daily

Stay updated with breaking news from Calcimedica daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

CalciMedica, Inc. (NASDAQ:CALC) Forecasted to Post Q2 2024 Earnings of ($0.42) Per Share

CalciMedica, Inc. (NASDAQ:CALC – Free Report) – Equities research analysts at HC Wainwright increased their Q2 2024 earnings per share (EPS) estimates for shares of CalciMedica in a report issued on Tuesday, May 14th. HC Wainwright analyst J. Pantginis now anticipates that the company will earn ($0.42) per share for the quarter, up from their […]

Nasdaq , Calcimedica-inc , Capital-management , Free-report , Get-free-report , Bay-capital-management , Meritage-portfolio-management , Portfolio-management , Calcimedica-daily ,

Meritage Portfolio Management Purchases 36,000 Shares of CalciMedica, Inc. (NASDAQ:CALC)

Meritage Portfolio Management lifted its holdings in shares of CalciMedica, Inc. (NASDAQ:CALC – Free Report) by 360.0% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 46,000 shares of the company’s stock after purchasing an additional 36,000 shares during the period. Meritage Portfolio Management owned 0.81% of CalciMedica […]

Calcimedica-inc , Capital-management , Nasdaq , Meritage-portfolio-management , Free-report , Portfolio-management , Get-free-report , Visit-holdingschannel , Calcimedica-daily , Calcimedica , Nasdaq-calc

Meritage Portfolio Management Raises Position in CalciMedica, Inc. (NASDAQ:CALC)

Meritage Portfolio Management boosted its holdings in shares of CalciMedica, Inc. (NASDAQ:CALC – Free Report) by 360.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 46,000 shares of the company’s stock after buying an additional 36,000 shares during the period. Meritage Portfolio Management’s holdings in […]

Capital-management , Calcimedica-inc , Nasdaq , Meritage-portfolio-management , Free-report , Portfolio-management , Get-free-report , Visit-holdingschannel , Calcimedica-daily ,

CalciMedica (NASDAQ:CALC) Receives Buy Rating from HC Wainwright

HC Wainwright restated their buy rating on shares of CalciMedica (NASDAQ:CALC – Free Report) in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a $20.00 price target on the stock. Separately, Oppenheimer reissued an outperform rating and set a $14.00 price objective on shares of CalciMedica in a report […]

Freda-middleton , Capital-management , Calcimedica-inc , Free-report , Medica-stock-down , Director-fred , Portfolio-management , Hudson-bay-capital-management , Get-free-report , Calcimedica-daily , Calcimedica

HC Wainwright Reaffirms Buy Rating for CalciMedica (NASDAQ:CALC)

HC Wainwright Reaffirms Buy Rating for CalciMedica (NASDAQ:CALC)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Freda-middleton , Calcimedica-inc , Securities-exchange-commission , Capital-management , Calcimedica-company-profile , Free-report , Get-free-report , Exchange-commission , Director-fred , Portfolio-management , Hudson-bay-capital-management

CalciMedica (NASDAQ:CALC) Trading Down 5.6%

CalciMedica, Inc. (NASDAQ:CALC – Get Free Report) shares were down 5.6% on Tuesday . The company traded as low as $3.66 and last traded at $3.66. Approximately 16,938 shares were traded during mid-day trading, a decline of 8% from the average daily volume of 18,312 shares. The stock had previously closed at $3.87. Wall Street […]

Nasdaq , Calcimedica-inc , Get-free-report , Medica-stock-down , Calcimedica-daily ,

CalciMedica (NASDAQ:CALC) Trading Down 5.6%

CalciMedica, Inc. (NASDAQ:CALC – Get Free Report)’s stock price was down 5.6% on Tuesday . The stock traded as low as $3.66 and last traded at $3.66. Approximately 16,938 shares were traded during trading, a decline of 8% from the average daily volume of 18,312 shares. The stock had previously closed at $3.87. Analyst Upgrades […]

Nasdaq , Calcimedica-inc , Calcimedica-company-profile , Get-free-report , Medica-trading-down , Calcimedica-daily ,

Contrasting CalciMedica (NASDAQ:CALC) & Atea Pharmaceuticals (NASDAQ:AVIR)

CalciMedica (NASDAQ:CALC – Get Rating) and Atea Pharmaceuticals (NASDAQ:AVIR – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, analyst recommendations, valuation, earnings and risk. Insider and Institutional Ownership 71.3% of Atea Pharmaceuticals shares are […]

California , United-states , Massachusetts , La-jolla , Boston , Calcimedica-inc , Merck-co-inc , Atea-pharmaceuticals-inc , Atea-pharmaceuticals , Get-rating , Atea-pharmaceutical

CalciMedica (CALC) and The Competition Financial Contrast

CalciMedica (NASDAQ:CALC – Get Rating) is one of 952 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it contrast to its competitors? We will compare CalciMedica to related companies based on the strength of its analyst recommendations, valuation, earnings, dividends, profitability, institutional ownership and risk. Analyst Recommendations This is a summary of recent […]

California , United-states , La-jolla , Calcimedica-inc , Get-rating , Given-calcimedica , Calcimedica-daily ,

CalciMedica (NASDAQ:CALC) Stock Price Up 0.3%

CalciMedica, Inc. (NASDAQ:CALC – Get Rating)’s share price rose 0.3% on Monday . The company traded as high as $5.55 and last traded at $5.29. Approximately 14,644 shares traded hands during mid-day trading, an increase of 76% from the average daily volume of 8,312 shares. The stock had previously closed at $5.28. Wall Street Analyst […]

Calcimedica-inc , Calcimedica-company-profile , Nasdaq , Get-rating , Calcimedica-daily , Calcimedica , Nasdaq-calc , Calc , Medical , Stocks , Technicals